Those requirements can make it more difficult to access Spravato. Some people also experience uncomfortable side effects from oral antidepressants, such as weight gain, decreased libido, or mood ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

Here's what doctors want you to know about Spravato, plus potential side effects to be aware of. Thea Gallagher, PsyD, is a clinical associate professor at NYU Langone Health and cohost of the ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral antidepressants.

( MENAFN - EIN Presswire) Spravato® (esketamine) has been approved for use as a standalone treatment for depression, without the requirement of an accompanying antidepressant. Legal Disclaimer: ...

These side effects and the potential risk of harmful dependence have led to the FDA mandating a special treatment strategy for providing Spravato to patients, known as a Risk Evaluation and ...

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the immediate impact Spravato has had on patients with treatment-resistant ...

Spravato’s warning label cautions about the risk of sedation and dissociation, respiratory depression, suicidal thoughts, and abuse or misuse of the drug, among other potential side effects.

It may cause mild side effects, such as abdominal pain, or more serious side effects, such as diabetic retinopathy. Keep reading to learn about the common, mild, and serious side effects that ...